Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0028 Transporter Info
Gene Name	SLC47A2
Transporter Name	Multidrug and toxin extrusion protein 2
Gene ID	146802
UniProt ID	Q86VL8

Post-Translational Modification of This DT
Overview of SLC47A2 Modification Sites with Functional and Structural Information
Sequence	M D S L Q D T V A L D H G G C C P A L S R L V P R G F G T E M W T L F A L S G P L F L F Q V L T F M I Y I V S T V F C G H L G K V E L A S V T L A V A F V N V C G V S V G V G L S S A C D T L M S Q S F G S P N K K H V G V I L Q R G A L V L L L C C L P C W A L F L N T Q H I L L L F R Q D P D V S R L T Q D Y V M I F I P G L P V I F L Y N L L A K Y L Q N Q G W L K G Q E E E S P F Q T P G L S I L H P S H S H L S R A S F H L F Q K I T W P Q V L S G V V G N C V N G V A N Y A L V S V L N L G V R G S A Y A N I I S Q F A Q T V F L L L Y I V L K K L H L E T W A G W S S Q C L Q D W G P F F S L A V P S M L M I C V E W W A Y E I G S F L M G L L S V V D L S A Q A V I Y E V A T V T Y M I P L G L S I G V C V R V G M A L G A A D T V Q A K R S A V S G V L S I V G I S L V L G T L I S I L K N Q L G H I F T N D E D V I A L V S Q V L P V Y S V F H V F E A I C C V Y G G V L R G T G K Q A F G A A V N A I T Y Y I I G L P L G I L L T F V V R M R I M G L W L G M L A C V F L A T A A F V A Y T A R L D W K L A A E E A K K H S G R Q Q Q Q R A E S T A T R P G P E K A V L S S V A T G S S P G I T L T T Y S R S E C H V D F F R T P E E A H A L S A P T S R L S V K Q L V I R R G A A L G A A S A T L M V G L T V R I L A T R H
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A2			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	387
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 387 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 515 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	528
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 528 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	529
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 529 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	534
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 534 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	535
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 535 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC47A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Serine 544 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC47A2			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	532
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC47A2 Threonine 532 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Inhibiting the function of SLC47A2			[5]
Role of PTM	On/Off Switch
Affected Drug/Substrate	Cisplatin	Results for Drug	Decreasing uptake of cisplatin specificity
Modified Residue	Tyrosine
Modified State	Tyrosine kinase inhibitors (Pazopanib)
Experimental Material(s)	Human embryonic kidney (HEK) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at SLC47A2 Tyrosine (i.e. Tyrosine kinase inhibitors (Pazopanib)) have been reported to inhibit its transport function.

References
1	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
3	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4	Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer. Anal Chem. 2010 Feb 1;82(3):824-32.
5	Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res. 2016 Aug;110:89-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence